Rituximab as first-line treatment of pemphigus

Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease

Christoph T. Ellebrecht, Vijay Bhoj, Arben Nace et al. · Science · 2016 · 707 citations · Full text

Life Sciences, Immunology, Molecular Medicine +17

First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial

P. Joly, Maud Maho‐Vaillant, C. Prost‐Squarcioni et al. · The Lancet · 2017 · 596 citations

Medicine, Internal Medicine, Pharmacotherapy +9

A Single Cycle of Rituximab for the Treatment of Severe Pemphigus

P. Joly, Hugo Mouquet, Jean‐Claude Roujeau et al. · New England Journal of Medicine · 2007 · 462 citations

Life Sciences, Immunology, Pharmacotherapy +8

Treatment of Pemphigus Vulgaris with Rituximab and Intravenous Immune Globulin

A. R. Ahmed, Zachary Spigelman, Lisa A. Cavacini et al. · New England Journal of Medicine · 2006 · 452 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +8

Treatment of Pemphigus Vulgaris with Rituximab and Intravenous Immune Globulin

J.A. Stockman · Yearbook of Pediatrics · 2008 · 405 citations

Life Sciences, Immunology, Pharmacotherapy +8